These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10209926)

  • 21. "Second hit" in sebaceous tumors from Muir-Torre patients with germline mutations in MSH2: allele loss is not the preferred mode of inactivation.
    Kruse R; Rütten A; Hosseiny-Malayeri HR; Bisceglia M; Friedl W; Propping P; Ruzicka T; Mangold E
    J Invest Dermatol; 2001 Mar; 116(3):463-5. PubMed ID: 11231323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 staining correlates with tumor type and location in sebaceous neoplasms.
    Shalin SC; Sakharpe A; Lyle S; Lev D; Calonje E; Lazar AJ
    Am J Dermatopathol; 2012 Apr; 34(2):129-35; quiz 136-8. PubMed ID: 22441365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muir-Torre syndrome and defective DNA mismatch repair genes.
    Fusaro RM; Lemon SJ; Lynch HT
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):493-4. PubMed ID: 8784301
    [No Abstract]   [Full Text] [Related]  

  • 24. Loss of fragile histidine triad (FHIT) expression and microsatellite instability in periocular sebaceous gland carcinoma in patients with Muir-Torre syndrome.
    Holbach LM; von Moller A; Decker C; Jünemann AG; Rummelt-Hofmann C; Ballhausen WG
    Am J Ophthalmol; 2002 Jul; 134(1):147-8. PubMed ID: 12095833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eyelid sebaceous carcinoma associated with Muir-Torre syndrome in two cases.
    Demirci H; Nelson CC; Shields CL; Eagle RC; Shields JA
    Ophthalmic Plast Reconstr Surg; 2007; 23(1):77-9. PubMed ID: 17237705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muir-Torre syndrome.
    Johnson PJ; Heckler F
    Ann Plast Surg; 1998 Jun; 40(6):676-7. PubMed ID: 9641292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutation analysis of CTNNB1 gene and the ras pathway genes KRAS, NRAS, BRAF, and PIK3CA in eyelid sebaceous carcinomas.
    Kwon MJ; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY
    Pathol Res Pract; 2017 Jun; 213(6):654-658. PubMed ID: 28551389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test.
    Mathiak M; Rütten A; Mangold E; Fischer HP; Ruzicka T; Friedl W; Propping P; Kruse R
    Am J Surg Pathol; 2002 Mar; 26(3):338-43. PubMed ID: 11859205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sebaceous lesions of the skin.
    Iacobelli J; Harvey NT; Wood BA
    Pathology; 2017 Dec; 49(7):688-697. PubMed ID: 29078997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extraocular sebaceous carcinoma in a patient with Muir-Torre syndrome.
    Harrington CR; Egbert BM; Swetter SM
    Dermatol Surg; 2004 May; 30(5):817-9. PubMed ID: 15099333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Universal immunohistochemical screening of sebaceous neoplasms for Muir-Torre syndrome: Putting the cart before the horse?
    Kim RH; Nagler AR; Meehan SA
    J Am Acad Dermatol; 2016 Nov; 75(5):1078-1079. PubMed ID: 27745640
    [No Abstract]   [Full Text] [Related]  

  • 32. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability, and immunohistochemistry.
    Ponti G; Losi L; Di Gregorio C; Roncucci L; Pedroni M; Scarselli A; Benatti P; Seidenari S; Pellacani G; Lembo L; Rossi G; Marino M; Lucci-Cordisco E; Ponz de Leon M
    Cancer; 2005 Mar; 103(5):1018-25. PubMed ID: 15662714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microsatellite instability and mismatch repair protein expression in sebaceous tumors, keratocanthoma, and basal cell carcinomas with sebaceous differentiation in Muir-Torre syndrome.
    Ponti G; Longo C
    J Am Acad Dermatol; 2013 Mar; 68(3):509-10. PubMed ID: 23394915
    [No Abstract]   [Full Text] [Related]  

  • 34. Genitourinary tumors in men with the Muir-Torre syndrome.
    Davis DA; Cohen PR
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 2):909-12. PubMed ID: 7593809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Muir-Torre syndrome: a disease of sebaceous and colonic neoplasms.
    Schwartz RA; Goldberg DJ; Mahmood F; DeJager RL; Lambert WC; Najem AZ; Cohen PJ
    Dermatologica; 1989; 178(1):23-8. PubMed ID: 2917677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Muir-Torre syndrome. Diagnostic criteria and review of the literature].
    Hartig C; Stieler W; Stadler R
    Hautarzt; 1995 Feb; 46(2):107-13. PubMed ID: 7706067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Muir-Torre syndrome: a case of two brothers.
    Gáspár K; Veres I; Hunyadi J; Juhász I
    Int J Dermatol; 2006 Sep; 45(9):1124-6. PubMed ID: 16961537
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinicopathological relevance of the association between gastrointestinal and sebaceous neoplasms: the Muir-Torre syndrome.
    Paraf F; Sasseville D; Watters AK; Narod S; Ginsburg O; Shibata H; Jothy S
    Hum Pathol; 1995 Apr; 26(4):422-7. PubMed ID: 7705822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Torre-Muir syndrome. Sebaceous gland tumors indicate colon carcinoma and other internal malignant tumors].
    Karsten U; Christophers E; Sterry W
    Dtsch Med Wochenschr; 1987 Aug; 112(34):1296-301. PubMed ID: 3622267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.
    Abbas O; Mahalingam M
    J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.